Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9319970 | European Urology | 2005 | 12 Pages |
Abstract
The prospect of a pharmacological, male contraceptive has been considerably advanced in recent years. Long-term studies involving a greater number of subjects may result in a safe, reversible and effective means. Asia is likely to be the first market for male, hormonal contraceptive methods. The clinical evaluation of non-endocrine approaches may ultimately lead to an alternative to hormone-based male contraception.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
C.E. Hoesl, F. Saad, M. Pöppel, J.E. Altwein,